Wall Street brokerages expect that Orthopediatrics Corp (NASDAQ:KIDS) will post ($0.22) earnings per share (EPS) for the current fiscal quarter, Zacks reports. Three analysts have provided estimates for Orthopediatrics’ earnings. The lowest EPS estimate is ($0.27) and the highest is ($0.18). Orthopediatrics reported earnings of ($0.19) per share in the same quarter last year, which would suggest a negative year over year growth rate of 15.8%. The firm is expected to report its next earnings report on Wednesday, March 4th.
On average, analysts expect that Orthopediatrics will report full-year earnings of ($0.82) per share for the current year, with EPS estimates ranging from ($0.88) to ($0.76). For the next financial year, analysts forecast that the business will post earnings of ($0.35) per share, with EPS estimates ranging from ($0.55) to ($0.15). Zacks’ earnings per share averages are a mean average based on a survey of sell-side research analysts that that provide coverage for Orthopediatrics.
Orthopediatrics (NASDAQ:KIDS) last posted its earnings results on Thursday, November 7th. The company reported ($0.18) EPS for the quarter, missing the consensus estimate of ($0.17) by ($0.01). The business had revenue of $20.74 million during the quarter, compared to analysts’ expectations of $19.87 million. Orthopediatrics had a negative net margin of 15.80% and a negative return on equity of 12.22%. The business’s quarterly revenue was up 31.1% compared to the same quarter last year. During the same period last year, the company earned ($0.15) EPS.
Several institutional investors and hedge funds have recently made changes to their positions in the company. Calamos Advisors LLC bought a new stake in Orthopediatrics in the 2nd quarter valued at $2,373,000. Vanguard Group Inc. raised its holdings in shares of Orthopediatrics by 4.8% in the second quarter. Vanguard Group Inc. now owns 457,646 shares of the company’s stock valued at $17,848,000 after purchasing an additional 20,799 shares during the last quarter. BlackRock Inc. increased its holdings in Orthopediatrics by 16.8% during the second quarter. BlackRock Inc. now owns 585,555 shares of the company’s stock worth $22,837,000 after buying an additional 84,205 shares during the last quarter. Russell Investments Group Ltd. acquired a new position in Orthopediatrics during the second quarter worth $2,055,000. Finally, Bank of America Corp DE boosted its position in Orthopediatrics by 9.9% during the second quarter. Bank of America Corp DE now owns 35,316 shares of the company’s stock worth $1,377,000 after purchasing an additional 3,175 shares during the period. Institutional investors and hedge funds own 50.42% of the company’s stock.
NASDAQ:KIDS traded up $0.57 during trading hours on Tuesday, hitting $38.07. The company’s stock had a trading volume of 3,028 shares, compared to its average volume of 53,956. The stock has a market capitalization of $560.23 million, a P/E ratio of -39.66 and a beta of 0.23. The stock has a fifty day moving average of $36.27 and a 200-day moving average of $36.99. The company has a current ratio of 2.53, a quick ratio of 1.75 and a debt-to-equity ratio of 0.24. Orthopediatrics has a 52-week low of $25.11 and a 52-week high of $47.82.
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.